Hyro Secures Spot in the 2026 New York Digital Health 100 List
Hyro, a frontrunner in the application of responsible AI agents for healthcare, has recently been honored with a spot on the 2026 New York Digital Health 100. This prestigious recognition showcases the innovators who are significantly impacting the digital health landscape in New York City. Announced on February 3, 2026, by Digital Health New York (DHNY), the Digital Health 100 is an annual list highlighting startups that exemplify innovation, originality, and effectiveness in improving patient care.
This year's list includes 48 newcomers, all of whom contribute to tackling complex healthcare challenges through ingenious solutions. Among these, Hyro stands out with its mission to streamline healthcare access while enhancing patient engagement. Israel Krush, the co-founder and CEO of Hyro, expressed pride in this acknowledgment, describing it as a testament to Hyro's commitment to simplifying healthcare journeys through intelligent, human-like interactions.
As the only AI-driven platform recognized in the DH100, Hyro's Responsible AI Agent Platform has gained traction, showing a remarkable engagement with over 30 million patients while automating routine interactions by over 85%. Such metrics exemplify how Hyro is reshaping not just patient access but operational efficiencies for numerous healthcare organizations.
The inclusion in the DH100 also reflects a notable shift within the healthcare sector from mere experimentation to tangible execution. Bunny Ellerin, co-founder and CEO of DHNY, emphasized that this year's selections mirror how companies are evolving their solutions to improve outcomes sustainably while simultaneously building robust businesses. Hyro’s growth has been accentuated by a recent strategic funding round of $45 million, bringing its total backing to around $95 million. This financial infusion is set to bolster the capabilities of its AI solutions, including its innovative Proactive Px™ feature, aimed at enhancing patient outreach.
With partnerships spanning over 50 leading health systems, including notable organizations like Tampa General Hospital and Sutter Health, Hyro's impact extends across significant healthcare facilities where its technology aims to ease and expedite the care process. Headquartered in New York City, Hyro's position within this vibrant ecosystem allows for close collaboration with other innovative entities that are similarly invested in the future of healthcare.
Hyro’s AI agents are not just enhancing patient interactions; they are also ensuring that healthcare becomes accessible and efficient. By removing friction from the patient journey, Hyro enables healthcare systems to provide timely and accurate guidance to patients, allowing them to navigate their healthcare experiences with confidence.
The 2026 New York Healthcare Innovation Report, accompanying the DH100 announcement, provides insights into key investment trends and market dynamics shaping digital health. This report serves as a valuable resource for understanding how innovations are driving change across the sector. To gain deeper insights and access the findings, readers can download the report for a comprehensive understanding of the digital health landscape.
Overall, being a part of the 2026 New York Digital Health 100 is a significant acknowledgment for Hyro, reinforcing its role as a leader in responsible AI within healthcare. With the ongoing evolution in healthcare technology, companies like Hyro are paving the way for a future where technology and patient care converge to deliver unparalleled levels of service and convenience. For more information about Hyro’s innovative solutions and their applications in healthcare, one can visit their website at www.hyro.ai.
This year's list includes 48 newcomers, all of whom contribute to tackling complex healthcare challenges through ingenious solutions. Among these, Hyro stands out with its mission to streamline healthcare access while enhancing patient engagement. Israel Krush, the co-founder and CEO of Hyro, expressed pride in this acknowledgment, describing it as a testament to Hyro's commitment to simplifying healthcare journeys through intelligent, human-like interactions.
As the only AI-driven platform recognized in the DH100, Hyro's Responsible AI Agent Platform has gained traction, showing a remarkable engagement with over 30 million patients while automating routine interactions by over 85%. Such metrics exemplify how Hyro is reshaping not just patient access but operational efficiencies for numerous healthcare organizations.
The inclusion in the DH100 also reflects a notable shift within the healthcare sector from mere experimentation to tangible execution. Bunny Ellerin, co-founder and CEO of DHNY, emphasized that this year's selections mirror how companies are evolving their solutions to improve outcomes sustainably while simultaneously building robust businesses. Hyro’s growth has been accentuated by a recent strategic funding round of $45 million, bringing its total backing to around $95 million. This financial infusion is set to bolster the capabilities of its AI solutions, including its innovative Proactive Px™ feature, aimed at enhancing patient outreach.
With partnerships spanning over 50 leading health systems, including notable organizations like Tampa General Hospital and Sutter Health, Hyro's impact extends across significant healthcare facilities where its technology aims to ease and expedite the care process. Headquartered in New York City, Hyro's position within this vibrant ecosystem allows for close collaboration with other innovative entities that are similarly invested in the future of healthcare.
Hyro’s AI agents are not just enhancing patient interactions; they are also ensuring that healthcare becomes accessible and efficient. By removing friction from the patient journey, Hyro enables healthcare systems to provide timely and accurate guidance to patients, allowing them to navigate their healthcare experiences with confidence.
The 2026 New York Healthcare Innovation Report, accompanying the DH100 announcement, provides insights into key investment trends and market dynamics shaping digital health. This report serves as a valuable resource for understanding how innovations are driving change across the sector. To gain deeper insights and access the findings, readers can download the report for a comprehensive understanding of the digital health landscape.
Overall, being a part of the 2026 New York Digital Health 100 is a significant acknowledgment for Hyro, reinforcing its role as a leader in responsible AI within healthcare. With the ongoing evolution in healthcare technology, companies like Hyro are paving the way for a future where technology and patient care converge to deliver unparalleled levels of service and convenience. For more information about Hyro’s innovative solutions and their applications in healthcare, one can visit their website at www.hyro.ai.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.